Strategic Alliances with PharmaJet
Many leading pharmaceutical, biotechnology, and academic institutions have formed strategic alliances with PharmaJet to use our needle-free injection systems to enhance the delivery of their injected medicines and vaccines.
Needle-free delivery provides a safe and often, more effective alternative to traditional injection techniques. We have needle-free devices for 0.1 ml (intradermal) and 0.5 ml (subcutaneous and intramuscular) dose volumes. Variable dose devices are in late stages of development.
Click on image to enlarge
Our Needle-free Injection Systems Effectively Deliver
✓ Low and high viscosity medicines
✓ Proteins and peptides
✓ Specialty drug therapies
✓ Nucleic acid-based vaccines and therapeutics
[tropis_info]
PharmaJet Vaccine Partnerships
We are interested in collaboration opportunities with partners where our technology can enhance the delivery of injectables in areas such as biologics, vaccines, small molecules, and other therapeutic technology platforms.
PharmaJet currently has active strategic collaborations with a wide variety of partners including emerging biotechnology companies, established pharmaceutical companies, Armed Forces/DoD (Department of Defense), Federal Agencies, among others.
